Leprosy as a low prevalence disease
Autor(a) principal: | |
---|---|
Data de Publicação: | 1995 |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Hansenologia Internationalis (Online) |
Texto Completo: | https://periodicos.saude.sp.gov.br/hansenologia/article/view/36486 |
Resumo: | With the rapid progress in the control of leprosy due to the implementation of WHOMDT and the positive modification carried out in the health services system that accompanied MDT introduction, the prevalence of leprosy is facing a steady reduction worldwide, making possible that inthe next 10 years leprosy becomes a low prevalence disease in endemic countries. At this stage, components of a leprosy control program should be reviewed as concern their priority. Maintenance of diagnosis and treatment services, supervision and an attentive surveillance system are fundamental. Support to Reference Centers is mandatory to guarantee their role as reservoir of knowledge and for the development of research still in need. POD and rehabilitation will play a predominant role provided leprosy is, at that time, to be regarded as a disability-and deformity- producing disease and there will be more time and funds available to be allocated to these activities since a significant load of cases in need for these activities will do exist, which should not and could not be ignored. From available data in the literature, the author presents an estimation on the size of the problem and suggest the adoption of new indicators. |
id |
ILSL-1_522704f31d61d69c078b7f001cf5cad7 |
---|---|
oai_identifier_str |
oai:ojs.periodicos.saude.sp.gov.br:article/36486 |
network_acronym_str |
ILSL-1 |
network_name_str |
Hansenologia Internationalis (Online) |
repository_id_str |
|
spelling |
Leprosy as a low prevalence diseaseA hanseníase como doença de baixa prevalênciabaixa-prevalênciaPrevenção de IncapacidadesProgramas de controlelow prevalencePrevention of DisabilitiesLeprosy Control ProgramsWith the rapid progress in the control of leprosy due to the implementation of WHOMDT and the positive modification carried out in the health services system that accompanied MDT introduction, the prevalence of leprosy is facing a steady reduction worldwide, making possible that inthe next 10 years leprosy becomes a low prevalence disease in endemic countries. At this stage, components of a leprosy control program should be reviewed as concern their priority. Maintenance of diagnosis and treatment services, supervision and an attentive surveillance system are fundamental. Support to Reference Centers is mandatory to guarantee their role as reservoir of knowledge and for the development of research still in need. POD and rehabilitation will play a predominant role provided leprosy is, at that time, to be regarded as a disability-and deformity- producing disease and there will be more time and funds available to be allocated to these activities since a significant load of cases in need for these activities will do exist, which should not and could not be ignored. From available data in the literature, the author presents an estimation on the size of the problem and suggest the adoption of new indicators.Devido os rápidos avanços no controle da hanseníase obtidos pela introdução da PQT e as positivas modificações que ocorreram nos serviços de saúde, a hanseníase encontra-se em franco declínio de prevalência, permitindo que se tome, nos países endêmicos, uma doença de baixa prevalência no próximos 10 anos. Nesta fase, os elementos de um programa de controle deverão ser modificados ou ter sua prioridade revista. A manutenção de serviços de diagnostico e tratamento, a supervisão, e um atento sistema de vigilância epidemiológica serão fundamentais. Importante o apoio aos Centros de Referência para que se mantenham como reserva de conhecimentos e atuem no desenvolvimento de pesquisas ainda necessárias. A prevenção de incapacidades e a reabilitação assumem papel preponderante, uma vez que nesta fase a hanseníase devera voltar a ser considerada como doença de potencial incapacitante, haverá maior disponibilidade de recursos humanos e materiais para atender uma demanda importante e que não pode ser ignorada. Discute-se também, baseados em dados da literatura, uma estimativa para a magnitude do problema e sugere-se a introdução de novos indicadores.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo1995-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3648610.47878/hi.1995.v20.36486Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 20 No. 2 (1995); 27-35Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 20 n. 2 (1995); 27-351982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLporenghttps://periodicos.saude.sp.gov.br/hansenologia/article/view/36486/34771https://periodicos.saude.sp.gov.br/hansenologia/article/view/36486/34772https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessVirmond, Marcos2023-10-10T13:26:37Zoai:ojs.periodicos.saude.sp.gov.br:article/36486Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2023-10-10T13:26:37Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false |
dc.title.none.fl_str_mv |
Leprosy as a low prevalence disease A hanseníase como doença de baixa prevalência |
title |
Leprosy as a low prevalence disease |
spellingShingle |
Leprosy as a low prevalence disease Virmond, Marcos baixa-prevalência Prevenção de Incapacidades Programas de controle low prevalence Prevention of Disabilities Leprosy Control Programs |
title_short |
Leprosy as a low prevalence disease |
title_full |
Leprosy as a low prevalence disease |
title_fullStr |
Leprosy as a low prevalence disease |
title_full_unstemmed |
Leprosy as a low prevalence disease |
title_sort |
Leprosy as a low prevalence disease |
author |
Virmond, Marcos |
author_facet |
Virmond, Marcos |
author_role |
author |
dc.contributor.author.fl_str_mv |
Virmond, Marcos |
dc.subject.por.fl_str_mv |
baixa-prevalência Prevenção de Incapacidades Programas de controle low prevalence Prevention of Disabilities Leprosy Control Programs |
topic |
baixa-prevalência Prevenção de Incapacidades Programas de controle low prevalence Prevention of Disabilities Leprosy Control Programs |
description |
With the rapid progress in the control of leprosy due to the implementation of WHOMDT and the positive modification carried out in the health services system that accompanied MDT introduction, the prevalence of leprosy is facing a steady reduction worldwide, making possible that inthe next 10 years leprosy becomes a low prevalence disease in endemic countries. At this stage, components of a leprosy control program should be reviewed as concern their priority. Maintenance of diagnosis and treatment services, supervision and an attentive surveillance system are fundamental. Support to Reference Centers is mandatory to guarantee their role as reservoir of knowledge and for the development of research still in need. POD and rehabilitation will play a predominant role provided leprosy is, at that time, to be regarded as a disability-and deformity- producing disease and there will be more time and funds available to be allocated to these activities since a significant load of cases in need for these activities will do exist, which should not and could not be ignored. From available data in the literature, the author presents an estimation on the size of the problem and suggest the adoption of new indicators. |
publishDate |
1995 |
dc.date.none.fl_str_mv |
1995-11-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/36486 10.47878/hi.1995.v20.36486 |
url |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/36486 |
identifier_str_mv |
10.47878/hi.1995.v20.36486 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/36486/34771 https://periodicos.saude.sp.gov.br/hansenologia/article/view/36486/34772 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
dc.source.none.fl_str_mv |
Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 20 No. 2 (1995); 27-35 Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 20 n. 2 (1995); 27-35 1982-5161 reponame:Hansenologia Internationalis (Online) instname:Instituto Lauro de Souza Lima (ILSL) instacron:ILSL |
instname_str |
Instituto Lauro de Souza Lima (ILSL) |
instacron_str |
ILSL |
institution |
ILSL |
reponame_str |
Hansenologia Internationalis (Online) |
collection |
Hansenologia Internationalis (Online) |
repository.name.fl_str_mv |
Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL) |
repository.mail.fl_str_mv |
hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br |
_version_ |
1796797581504806912 |